The global newborn screening market value reached at US$ 950 million in 2020 and predicted to surpass US$ 3.2 billion by 2030, expanding at a noteworthy CAGR of 11% from 2021 to 2030.
Newborn screening is a preventive pediatric screening test conducted to diagnose congenital or inborn abnormalities of metabolism in order to identify the disease. Newborn screening helps in the early detection of serious genetic diseases, which may result in disability or death if not treated at the initial stage. Different types of instrument and assay kits are used in the diagnosis of newborn disorders. Hearing screening devices and pulse oximeter are regularly used in the diagnosis of newborn disorders.
The growth of the global newborn screening market can be ascribed to the rise in prevalence of critical congenital heart defects and government support. The U.S. has a national program of newborn screening tests to check for several different disorders that can be treated, if found very early in life.
Rise in Prevalence of Critical Congenital Heart Defects and Government Support to Drive Global Market
Rise in prevalence and incidence of critical congenital heart diseases across the globe are driving the global newborn screening market. According to the National Center for Biotechnology Information, about 1.35 million babies are born with congenital heart disease each year across the globe. According to the Indian Academy of Pediatrics, more than 200,000 children are estimated to be born with CHD in India every year. About one-fifth of these suffer from critical heart disease that requires early intervention.
Supportive governmental programs and increase in funding for neonatal research also create a favorable environment for the expansion of the market. For instance, in June 2018, the American Society of Hematology (ASH) led a campaign to fight the sickle cell disease in Africa and urged governments, particularly in Sub-Saharan Africa, to invest in newborn screening of the disease.
Evaluation of Screening Methods Helps in Policy Recommendations for New Treatments
Healthcare providers in the newborn screening market are setting their collaboration wheels in motion to assess the current state of pediatric screening. Rare disease-focused organizations such as the EveryLife Foundation for Rare Diseases, Retrophin, Inc., BioMarin Pharmaceutical Inc., Orchard Therapeutics Inc., and Sarepta Therapeutics have joined forces to evaluate the capacity of newborn screening in the U.S. Timely diagnosis to all newborns who may benefit from new treatments requires careful evaluation from healthcare organizations.
The evaluation by organizations in the newborn screening market will ensure policy recommendations that enable equitable access to newborn screening for all babies in the U.S.
Medical Outcomes Increase with Connectivity Between Screening Programs and Healthcare Providers
Companies in the newborn screening market are focusing on reducing the morbidity and mortality associated with heritable disorders in newborns and children. Altarum - a non-profit research and consulting organization has been selected by the Health Resources and Services Administration (HRSA) to lead the Innovations in Newborn Screening Interoperability Resource Center. Such initiatives explain why the newborn screening market is expected to advance at a robust CAGR of ~11% during the forecast period.
In order to improve medical outcomes of newborns and children, healthcare providers are taking efforts to enhance the connectivity between state public health newborn screening programs and healthcare providers. This is being achieved with the help of information management and technical assistance for newborn screening programs.
Report Highlights
In terms of product, the global newborn screening market has been bifurcated into instruments and assay kits. The instruments segment has been split into tabletop and point-of-care testing. The instruments segment dominated the global newborn screening market in 2020. This trend is likely to continue during the forecast period. Instruments allow early detection and management of congenital disorders, thereby providing a better life to the affected infant. This is estimated to boost the segment during the forecast period. Major market players are focusing on the launch of new tabletop and point-of-care testing instruments for newborn screening. This is also likely to propel the segment during the forecast period.
Assay kits was the second-largest segment of the global market in 2020, in terms of market share. Increase in use of assay kit in newborn screening is projected to fuel the growth of the segment.
Based on test type, the global newborn screening market has been categorized into dry blood spot test, hearing screen test, critical congenital heart disease (CCHD) test, X-ray or CT scan, electrocardiogram (ECG) test, and others. The dry blood spot test segment accounted for a prominent share of the global newborn screening market in 2020. Dry blood spot test helps analyze specific biochemistry parameters, such as uric acid, cholesterol, triglycerides, glucose, and creatinine. The dry blood spot test can be used when a baby requires re-testing, as it provides a fast alternative to bringing the parents and infant back to the hospital for a new blood draw. This is critical, as many of the conditions screened for by newborn screening need to be diagnosed as quickly as possible. This is boosting the dry blood spot test segment.
In terms of end user, the global newborn screening market has been classified into hospitals, diagnostic centers, maternity & specialty clinics, and others. The hospitals segment led the global newborn screening market in terms of revenue in 2020. This trend is projected to continue during the forecast period. Rapid increase in the number of hospitals and wide range of services available in multispecialty hospitals are likely to augment the segment during the forecast period.
In terms of region, the global newborn screening market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global newborn screening market in 2020, followed by Europe. North America’s large market share can be ascribed to the increase in number of infants with critical congenital heart diseases, new product launches, and presence of major players in the region. The newborn screening market in Asia Pacific is anticipated to expand at a high CAGR from 2021 to 2030. This can be ascribed to the presence of developing countries with commercial hubs, expanding business organizations, rise in birth rate, improvement in healthcare infrastructure, and increase in investments by companies in research and development activity.
Key Players
The global newborn screening market is fragmented in terms of number of players. Key players operating in the global market include PerkinElmer, Inc., Trivitron Healthcare, Natus Medical Incorporated, Medtronic Plc, Thermo Fisher Scientific, Inc, Bio-Rad Laboratories, Inc., GE Healthcare (General Electric Company), ZenTech S.A., MP BIOMEDICALS, Baebies, Inc. and Masimo.
Global Newborn Screening Market: Segmentation
The Newborn screening market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Newborn screening market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Newborn screening market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Newborn screening market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Newborn screening market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Newborn screening capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Newborn screening by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Newborn screening market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Newborn screening market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Newborn screening market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Newborn screening industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Newborn screening market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Newborn screening market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Newborn screening market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Newborn screening market. These factors have benefited the growth of the global market for Newborn screening. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Newborn screening. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
Major Key Points Covered in Report:
Executive Summary: It includes key trends of the newborn screening market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the newborn screening market based on production and revenue.
Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.
Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Newborn screening market.
Market Segments: This part of the report discusses about product, application and other segments of the newborn screening market based on market share, CAGR, market size, and various other factors.
Research Methodology: This section discusses about the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.
In this study, the years considered to estimate the market size of Newborn screening are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Global Newborn Screening Market Forecast
4.4. Global Newborn Screening Market Outlook
5. Market Outlook
5.1. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.3. Overview of the Neonatal Research Funding/Grants
6. Global Newborn Screening Market Analysis, by Product
6.1. Introduction
6.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by Product
6.3. Global Newborn Screening Market Forecast, by Product
6.3.1. Instruments
6.3.1.1. Tabletop
6.3.1.2. Point-of-Care Testing
6.3.2. Assay Kits
6.4. Global Newborn Screening Market Analysis, by Product
7. Global Newborn Screening Market Analysis, by Test Type
7.1. Introduction
7.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
7.3. Global Newborn Screening Market Forecast, by Test Type
7.3.1. Dry Blood Spot Test
7.3.2. Hearing Screen Test
7.3.3. Critical Congenital Heart Disease (CCHD) Test
7.3.4. X-ray or CT Scan
7.3.5. Electrocardiogram (ECG) Test
7.3.6. Others
7.4. Global Newborn Screening Market Analysis, by Test Type
8. Global Newborn Screening Market Analysis, by End-user
8.1. Introduction
8.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
8.3. Global Newborn Screening Market Forecast, by End-user
8.3.1. Hospitals
8.3.2. Diagnostic Centers
8.3.3. Maternity & Specialty Clinics
8.3.4. Others
8.4. Global Newborn Screening Market Analysis, by End-user
9. Global Newborn Screening Market Analysis, by Region
9.1. Global Newborn Screening Market Scenario, by Region/Country
9.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by Region
9.3. Global Newborn Screening Market Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
10. North America Newborn Screening Market Analysis
10.1. North America Newborn Screening Market Overview
10.2. North America Newborn Screening Market Value Share and Attractiveness Analysis, by Country
10.3. North America Newborn Screening Market Forecast, by Country
10.3.1. U.S.
10.3.2. Canada
10.4. North America Newborn Screening Market Value Share and Attractiveness Analysis, by Product
10.5. North America Newborn Screening Market Forecast, by Product
10.5.1. Instruments
10.5.1.1. Tabletop
10.5.1.2. Point-of-Care Testing
10.5.2. Assay Kits
10.6. North America Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
10.7. North America Newborn Screening Market Forecast, by Test Type
10.7.1. Dry Blood Spot Test
10.7.2. Hearing Screen Test
10.7.3. Critical Congenital Heart Disease (CCHD) Test
10.7.4. X-ray or CT Scan
10.7.5. Electrocardiogram (ECG) Test
10.7.6. Others
10.8. North America Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
10.9. North America Newborn Screening Market Forecast, by End-user
10.9.1. Hospitals
10.9.2. Diagnostic Centers
10.9.3. Maternity & Specialty Clinics
10.9.4. Others
11. Europe Newborn Screening Market Analysis
11.1. Europe Newborn Screening Market Overview
11.2. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.3. Europe Newborn Screening Market Forecast, by Country/Sub-region
11.3.1. Germany
11.3.2. France
11.3.3. U.K.
11.3.4. Italy
11.3.5. Spain
11.3.6. Rest of Europe
11.4. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by Product
11.5. Europe Newborn Screening Market Forecast, by Product
11.5.1. Instruments
11.5.1.1. Tabletop
11.5.1.2. Point-of-Care Testing
11.5.2. Assay Kits
11.6. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
11.7. Europe Newborn Screening Market Forecast, by Test Type
11.7.1. Dry Blood Spot Test
11.7.2. Hearing Screen Test
11.7.3. Critical Congenital Heart Disease (CCHD) Test
11.7.4. X-ray or CT Scan
11.7.5. Electrocardiogram (ECG) Test
11.7.6. Others
11.8. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
11.9. Europe Newborn Screening Market Forecast, by End-user
11.9.1. Hospitals
11.9.2. Diagnostic Centers
11.9.3. Maternity & Specialty Clinics
11.9.4. Others
12. Asia Pacific Newborn Screening Market Analysis
12.1. Asia Pacific Newborn Screening Market Overview
12.2. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Asia Pacific Newborn Screening Market Forecast, by Country/Sub-region
12.3.1. Japan
12.3.2. China
12.3.3. India
12.3.4. South Korea
12.3.5. Rest of Asia Pacific
12.4. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by Product
12.5. Asia Pacific Newborn Screening Market Forecast, by Product
12.5.1. Instruments
12.5.1.1. Tabletop
12.5.1.2. Point-of-Care Testing
12.5.2. Assay Kits
12.6. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
12.7. Asia Pacific Newborn Screening Market Forecast, by Test Type
12.7.1. Dry Blood Spot Test
12.7.2. Hearing Screen Test
12.7.3. Critical Congenital Heart Disease (CCHD) Test
12.7.4. X-ray or CT Scan
12.7.5. Electrocardiogram (ECG) Test
12.7.6. Others
12.8. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
12.9. Asia Pacific Newborn Screening Market Forecast, by End-user
12.9.1. Hospitals
12.9.2. Diagnostic Centers
12.9.3. Maternity & Specialty Clinics
12.9.4. Others
13. Latin America Newborn Screening Market Analysis
13.1. Latin America Newborn Screening Market Overview
13.2. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Latin America Newborn Screening Market Forecast, by Country/Sub-region
13.3.1. Brazil
13.3.2. Mexico
13.3.3. Rest of Latin America
13.4. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by Product
13.5. Latin America Newborn Screening Market Forecast, by Product
13.5.1. Instruments
13.5.1.1. Tabletop
13.5.1.2. Point-of-Care Testing
13.5.2. Assay Kits
13.6. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
13.7. Latin America Newborn Screening Market Forecast, by Test Type
13.7.1. Dry Blood Spot Test
13.7.2. Hearing Screen Test
13.7.3. Critical Congenital Heart Disease (CCHD) Test
13.7.4. X-ray or CT Scan
13.7.5. Electrocardiogram (ECG) Test
13.7.6. Others
13.8. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
13.9. Latin America Newborn Screening Market Forecast, by End-user
13.9.1. Hospitals
13.9.2. Diagnostic Centers
13.9.3. Maternity & Specialty Clinics
13.9.4. Others
14. Middle East & Africa Newborn Screening Market Analysis
14.1. Middle East & Africa Newborn Screening Market Overview
14.2. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.3. Middle East & Africa Newborn Screening Market Forecast, by Country/Sub-region
14.3.1. GCC Countries
14.3.2. South Africa
14.3.3. Rest of Middle East & Africa
14.4. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by Product
14.5. Middle East & Africa Newborn Screening Market Forecast, by Product
14.5.1. Instruments
14.5.2. Tabletop
14.5.3. Point-of-Care Testing
14.5.4. Assay Kits
14.6. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
14.7. Middle East & Africa Newborn Screening Market Forecast, by Test Type
14.7.1. Dry Blood Spot Test
14.7.2. Hearing Screen Test
14.7.3. Critical Congenital Heart Disease (CCHD) Test
14.7.4. X-ray or CT Scan
14.7.5. Electrocardiogram (ECG) Test
14.7.6. Others
14.8. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
14.9. Middle East & Africa Newborn Screening Market Forecast, by End-user
14.9.1. Hospitals
14.9.2. Diagnostic Centers
14.9.3. Maternity & Specialty Clinics
14.9.4. Others
15. Competition Landscape
15.1. Competition Matrix
15.2. Company Share Analysis, 2019
15.3. Company Profiles
15.3.1. PerkinElmer, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Trivitron Healthcare
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. Natus Medical Incorporated
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Medtronic plc
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Thermo Fisher Scientific, Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Bio-Rad Laboratories, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. GE Healthcare (General Electric Company)
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. ZenTech S.A.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. MP BIOMEDICALS
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview
15.3.10. Baebies, Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Strategic Overview
15.3.11. Masimo
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Financial Overview
15.3.11.3. Product Portfolio
15.3.11.4. SWOT Analysis
15.3.11.5. Strategic Overview